Empirical Finance, LLC Biogen Inc. Transaction History

Empirical Finance, LLC

$1.59 Billion
Q2 2024

A detailed history of Empirical Finance, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Empirical Finance, LLC holds 4,969 shares of BIIB stock, worth $863,562. This represents 0.07% of its overall portfolio holdings.

Number of Shares

4,969

Previous 5,343 7.0%

Holding current value

$863,562

Previous $1.15 Million 0.09%

% of portfolio

0.07%

Previous 0.07%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$190.52 - $236.72 $71,254 - $88,533	-374 Reduced 7.0%	4,969 $1.15 Million
Q1 2024 May 06, 2024	BUY	$212.02 - $267.71 $42,191 - $53,274	199 Added 3.87%	5,343 $1.15 Million
Q3 2023 Nov 02, 2023	BUY	$253.3 - $285.89 $108,919 - $122,932	430 Added 9.12%	5,144 $1.32 Million
Q2 2023 Jul 27, 2023	BUY	$275.25 - $318.06 $146,157 - $168,889	531 Added 12.69%	4,714 $1.34 Million
Q1 2023 Apr 05, 2023	BUY	$256.56 - $292.34 $42,075 - $47,943	164 Added 4.08%	4,183 $1.16 Million
Q4 2022 Jan 24, 2023	BUY	$252.44 - $306.72 $72,955 - $88,642	289 Added 7.75%	4,019 $1.11 Million
Q3 2022 Nov 04, 2022	BUY	$194.69 - $268.46 $112,530 - $155,169	578 Added 18.34%	3,730 $996,000
Q2 2022 Aug 01, 2022	BUY	$187.54 - $223.02 $29,443 - $35,014	157 Added 5.24%	3,152 $643,000
Q1 2022 Apr 21, 2022	BUY	$193.77 - $244.14 $108,898 - $137,206	562 Added 23.1%	2,995 $631,000
Q4 2021 Feb 04, 2022	BUY	$223.92 - $287.77 $88,448 - $113,669	395 Added 19.38%	2,433 $584,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $543,057 - $708,206	-1,919 Reduced 48.5%	2,038 $577,000
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $1.38 Million - $2.21 Million	-5,325 Reduced 57.37%	3,957 $1.37 Million
Q4 2020 Feb 02, 2021	BUY	$236.26 - $355.63 $61,427 - $92,463	260 Added 2.88%	9,282 $2.27 Million
Q3 2020 Oct 28, 2020	BUY	$264.77 - $305.71 $709,848 - $819,608	2,681 Added 42.28%	9,022 $2.56 Million
Q3 2020 Oct 26, 2020	SELL	$264.77 - $305.71 $901,541 - $1.04 Million	-3,405 Reduced 34.94%	6,341 $1.48 Million
Q2 2020 Jul 20, 2020	BUY	$258.66 - $342.55 $1.28 Million - $1.7 Million	4,949 Added 103.17%	9,746 $2.61 Million
Q2 2020 Jul 20, 2020	SELL	$258.66 - $342.55 $1.22 Million - $1.62 Million	-4,726 Reduced 49.63%	4,797 $2.61 Million
Q1 2020 Apr 16, 2020	BUY	$268.85 - $341.04 $1.12 Million - $1.42 Million	4,157 Added 77.47%	9,523 $3.01 Million
Q4 2019 Jan 27, 2020	SELL	$220.06 - $304.07 $214,558 - $296,468	-975 Reduced 15.38%	5,366 $1.59 Million
Q3 2019 Oct 30, 2019	BUY	$217.44 - $243.88 $1.38 Million - $1.55 Million	6,341 New	6,341 $1.48 Million
Q3 2018 Oct 18, 2018	SELL	$293.51 - $383.83 $761,658 - $996,038	-2,595 Closed	0 $0
Q2 2018 Jul 09, 2018	BUY	$257.52 - $306.91 $668,264 - $796,431	2,595 New	2,595 $753,000
Q1 2018 Apr 25, 2018	SELL	$260.13 - $367.91 $938,288 - $1.33 Million	-3,607 Closed	0 $0
Q4 2017 Feb 01, 2018	SELL	$307.64 - $344.58 $71,064 - $79,597	-231 Reduced 6.02%	3,607 $1.15 Million
Q2 2017 Aug 10, 2017	BUY	N/A	3,838	3,838 $1.04 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.

Account

Empirical Finance, LLC Biogen Inc. Transaction History